Among patients with an established diagnosis of PBC, we confirmed that sCD163 is a marker of liver disease severity with increased levels in PBC patients with cirrhosis and in patients with an incomplete response to UDCA. This evidence concerns the gene CD163 and primary biliary cholangitis.